An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder ; volume:17 ; number:1 ; day:11 ; month:5 ; year:2018 ; pages:1-7 ; date:12.2018
Annals of general psychiatry ; 17, Heft 1 (11.5.2018), 1-7, 12.2018
- Creator
-
Shah, Anish
- Contributor
-
Northcutt, Joanne
SpringerLink (Online service)
- DOI
-
10.1186/s12991-018-0190-6
- URN
-
urn:nbn:de:101:1-2018071519470073756024
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shah, Anish
- Northcutt, Joanne
- SpringerLink (Online service)
Other Objects (12)
Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects
Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
Xenon in the treatment of panic disorder: an open label study
Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects
Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study
.Panic
Panic
-Panic.
Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects
Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
Xenon in the treatment of panic disorder: an open label study
Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects
Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study
.Panic
Panic
-Panic.
Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects
Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
Xenon in the treatment of panic disorder: an open label study
Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects
Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study
.Panic
Panic